Related Experiment Video
Updated: Jul 5, 2026
02:52
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
Zebrafish: a predictive model for assessing drug-induced toxicity.
1Phylonix, 100 Inman Street, Cambridge, MA 02139, USA. pat@phylonix.com
Drug Discovery Today
|May 13, 2008
Summary
Zebrafish offer a similar toxicity profile to mammals, making them ideal for early drug safety screening. This model allows for rapid elimination of unsafe compounds, saving time and resources in drug development.
Area of Science:
- Comparative toxicology
- Drug discovery and development
- Vertebrate model organisms
Background:
- Mammalian and zebrafish toxicity profiles show striking similarities.
- Zebrafish present experimental advantages such as transparency, convenient drug delivery, and low cost.
Purpose of the Study:
- To highlight the utility of zebrafish in drug toxicity and safety assessment.
- To emphasize the potential of zebrafish as a model for early-stage drug development.
Main Methods:
- Utilizing zebrafish as a model organism for toxicity testing.
- Leveraging experimental advantages of zebrafish, including drug delivery and cost-effectiveness.
Main Results:
- Zebrafish toxicity profiles are highly similar to mammalian models.
- Zebrafish enable rapid identification and prioritization of drug candidates.
Conclusions:
- Zebrafish serve as a valuable tool for early drug development, reducing risks and costs.
- Advancements in instrumentation and nanotechnology will further enhance zebrafish's role in drug screening.
